Elevance Health ELV 深 沪
等待开盘 02-03 09:30:00 美东时间
341.83
-3.910
-1.13%
华盛通- 最 高345.17
- 今 开342.29
- 成交量 190.29万股
- 最 低 339.11
- 昨 收 345.74
- 总市值 758.86亿
- 52周最高 453.62
- 市盈率 静 13.56
- 换手率 0.00%
- 52周最低 270.29
- 委 比 -56.86%
- 总股本 2.22亿
- 历史最高 557.16
- 量 比 0.59
- 振 幅 1.75%
- 历史最低 4.545
- 每 手 1
- 风险率 42.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 苹果、SanDisk、西部数据、卡特彼勒、德克斯户外、霍尼韦尔、西南航空、万事达等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Praxis Precision Medicine"买入"评级，目标价从340美元升至1245美元；HC Wainwright & Co.：维持Perspective Therapeutics"买入"评级，目标价从10美元升至12美元
02-02 14:15
U.S. RESEARCH ROUNDUP-Definium Therapeutics, Kenvue, Werner Enterprises
U.S. RESEARCH ROUNDUP-Definium Therapeutics, Kenvue, Werner Enterprises Jan 30 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Definium Therapeutics, Kenvue and Werner Enterprises on Friday. HIGHLIGHTS * Ameriprise Finan
01-30 15:45
美股大行评级 | Meta 、IBM、拉姆研究、布林克国际等获多家机构上调目标价；微软、特斯拉、ServiceNow、自动数据处理等遭多家下调评级
今日重点评级关注：Piper Sandler：上调Korro Bio评级至"超配"，目标价从11美元升至30美元；Piper Sandler：维持Nurix Therapeutics"超配"评级，目标价从32美元升至35美元
01-30 17:38
Analyst Expectations For Elevance Health's Future
During the last three months, 9 analysts shared their evaluations of Elevance H...
01-30 03:01
Elevance Health Inc. Publishes Transcript of Q4 2025 Earnings Call
Elevance Health Inc. Publishes Transcript of Q4 2025 Earnings Call Elevance Health Inc. has released the transcript of its Fourth Quarter 2025 earnings conference call, held on January 28, 2026. The event was attended by key members of the company’s leadership, including the President and Chief Exec
01-30 02:48
BUZZ-Street View: Elevance Health's forecast achievable, sees runway for improvement
BUZZ-Street View: Elevance Health's forecast achievable, sees runway for improvement ** Elevance Health ELV.N on Wednesday forecast full-year profit below Wall Street estimates, signaling elevated medical costs will continue to weigh on insurers MEDICAID 'SWING FACTORS' ** UBS ("buy", PT: $400) says
01-30 00:02
Guggenheim Maintains Buy on Elevance Health, Lowers Price Target to $396
Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $414 to $396.
01-29 22:49
U.S. RESEARCH ROUNDUP-AGNC Investment, Brown & Brown, Korro Bio
U.S. RESEARCH ROUNDUP-AGNC Investment, Brown & Brown, Korro Bio Jan 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including AGNC Investment, Brown & Brown and Korro Bio, on Thursday. HIGHLIGHTS * AGNC Investment Corp AGNC.O :
01-29 15:54
Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday?
Wall Street posted modest gains on Wednesday, while gold extended its relentless rally, shattering records above $5,300 an ounce ahead of the Federal Open Market Committee meeting.
01-29 02:01
财报速睇 | Elevance Health 2025财年Q4营收497.47亿美元，同比增长9.5%；归母净利润5.47亿美元，同比增长30.9%
华盛资讯1月29日讯，Elevance Health公布2025财年Q4业绩，公司Q4营收497.47亿美元，同比增长9.5%，归母净利润5.47亿美元，同比增长30.9%。
01-29 01:32
